Expand REPL Menu
REPL MENU

REPL Latest Press Releases

-- April 13, 2026 --

Replimune Group, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses Globe Newswire 7:45 AM

-- April 10, 2026 --

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma Globe Newswire 5:13 PM
Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma Globe Newswire 5:13 PM

-- March 2, 2026 --

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight PRNewswire 5:31 PM
Replimune to Present at Two Upcoming Investor Conferences Globe Newswire 8:00 AM

-- February 5, 2026 --

Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Replimune Group, Inc. (REPL), Sable Offshore Corp. (SOC), Sarepta Therapeutics, Inc. (SRPT), and Semler Scientific, Inc. (SMLR) Globe Newswire 10:47 AM

-- February 3, 2026 --

Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 8:00 AM

-- January 20, 2026 --

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Alto Neuroscience, Inc. (ANRO), Atkore Inc. (ATKR), Replimune Group, Inc. (REPL), and Fly-E Group, Inc. (FLYE) Globe Newswire 9:31 AM

-- December 18, 2025 --

Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes